trending Market Intelligence /marketintelligence/en/news-insights/trending/qyaboymhb0xzxo3-egxkag2 content esgSubNav
In This List

Scythian Biosciences to commence trading on Canadian Securities Exchange

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Scythian Biosciences to commence trading on Canadian Securities Exchange

Scythian Biosciences Corp. said its stock will start trading on the Canadian Securities Exchange starting Aug. 15.

The Toronto-based cannabis company's stock, which is also listed in Frankfurt and the OTC Market, will trade under the symbol SCYB.

"The TSX Venture Exchange policies required that we delist from the exchange prior to completion of any acquisitions of United States based cannabis companies. With our strategic expansion into the United States, it was determined best to delist from the TSX Venture Exchange at this point in time," Scythian CEO Rob Reid said in a statement.